Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Dec 16, 2022 11:58am
109 Views
Post# 35175932

RE:RE:RE:RE:RE:RE:RE:RE:Completely unprepared for this outcome

RE:RE:RE:RE:RE:RE:RE:RE:Completely unprepared for this outcome???
I think there are better opportunities to short out there.......(as you know too).

The fact is they created "a lot" of hope with the dosage, the way the trial went (according to them), their wording with "the key".....etc !! 

You are allready very long in TH (just like i am) and we cannot deny things are not going like they should go (should have gone) ...!

All those hiring, the O O , transition to a R&D company, way higher costs, money they don't have, loans at high %% ...etc!
Still no insiders willing to "take a shot", no partners willing to step up at these depressed prices, NASH on hold, ONCOLOGY paused.....

HOPE is again the word, hope that they can find a way out of this mess!!! 

GL

 


SPCEO1-

THTX reported bad news resulting in people shorting the stock. Various individuals (or maybe the same one with multiple profiles here) are spreading FUD because they are short. Don't take them too seriously (includuing their response to this post) as it is just their business model to create fear to help their short trade. Since we have free speech still, they get to spread the nonsense they do to support their short position just like bulls spread positive info. Unfortunately, free speech is so valuable it worth putting up with those who seek to abuse the privilege. Plus, you can always just ignore them, which I suspect is what most are doing. 

<< Previous
Bullboard Posts
Next >>